Ola Asem AliMPharm (Hons)

Ola Asem Mahmoud Abdou Ali

Senior Rotational Pharmacist · MPharm (Hons)

GPhC Reg. No. 2236654 · London, United Kingdom
ola.asem@nhs.net · +44 7510 340637 · LinkedIn · CV (PDF)

GPhC-registered Senior Rotational Pharmacist at London North West University Healthcare NHS Trust, working across acute hospital rotations.

Previous research includes Medical Affairs research at Pfizer UK and laboratory and quantitative research at the University of Nottingham in experimental pharmacology, nanotechnology, biomaterials and survey methods.

First-Class MPharm graduate with peer-reviewed publication and conference presentation experience.

Band 7
Current postSenior rotational pharmacist across acute hospital rotations, London North West University Healthcare NHS Trust
First Class
MPharm (Hons), NottinghamDean's Excellence Scholarship for performance in the top 10% of the cohort; highest cohort mark in four modules
Co-author
Real-world evidence study, Pfizer UKAI-assisted analysis of 618,682 public comments, of which 137,143 related to patients hospitalised for infection in England; presented at BSAC Spring Conference 2024
First author
Peer-reviewed reviewCNS & Neurological Disorders — Drug Targets (2022), alongside a co-authored Academic Press book chapter and two clinical education resources
Direction

Research interests

  • Pharmacoepidemiology and real-world evidence

    Using routinely collected and patient-generated data to quantify drug exposure, effectiveness and harm outside trial populations.

  • Medication safety and medicines optimisation

    Identifying and reducing preventable medicines-related harm, with focus on high-risk classes including anticoagulants and insulin.

  • AI and NLP for health data

    AI-assisted classification of unstructured patient narrative at scale, and its validity as a measure of care experience.

  • Treatment adherence and health inequalities

    Differential treatment outcomes across populations, and the structural determinants of adherence and access.

Experience

Research experience

Trainee Pharmacist, Medical Affairs

Pfizer UK

Aug 2023 – Jul 2024
  • Co-authored a real-world patient-experience study examining 618,682 public comments, including 137,143 relating to hospitalised patients treated for infection in England.
  • Applied AI-assisted classification of patient comments into person-centred care domains, with statistical comparison of experience scores across groups.
  • Presented findings at the British Society for Antimicrobial Chemotherapy (BSAC) Spring Conference 2024.
  • Authored evidence-based clinical prescribing resources on anticoagulants and insulin, translating pharmacology and national guidance into structured educational content.

Undergraduate Research Assistant

University of Nottingham

2020 – 2022
  • First-authored a peer-reviewed review on nanotechnology-enabled epilepsy treatment, synthesising evidence on blood–brain barrier penetration, bioavailability and the limitations of current therapy.
  • Optimised stereolithographic 3D printing of GelMA and GelMA-PEGDA hydrogels by varying formulation and printer parameters; synthesised hydrogels, designed constructs in TinkerCAD and assessed cell printability.
  • Co-developed a study of COVID-19 vaccine perceptions among Malaysians: formulated survey items, recruited participants and analysed responses in SPSS.
Publication record

Research and scholarly outputs

  1. 01
    Peer-reviewed article·First author

    Abdou Ali, O.A.M., Shaikh, M.F., Hasnain, M.S., Sami, F., Khan, A. and Ansari, M.T. (2022). Nanotechnological advances in the treatment of epilepsy.

    CNS & Neurological Disorders — Drug Targets, 21(10), 994–1003

    DOI: 10.2174/1871527321666211221162104
  2. 02
    Book chapter·Co-author

    Ansari, M.T., Srivastava, D., Abdou Ali, O.A.M., Hau, T.W., Sami, F. and Hasnain, M.S. (2024). Advances in semisolid dosage form.

    Dosage Forms, Formulation Developments, and Regulations: Recent and Future Trends in Pharmaceutics, Vol. 1, pp. 519–542. Academic Press

    DOI: 10.1016/B978-0-323-91817-6.00018-8
  3. 03
    Conference poster·Co-author

    Pask, B., Famokunwa, D., Amos, J., Kaur, M., Abdou Ali, O.A.M. and Gupta, A. (2024). Utilising social listening to better understand the experience of hospitalised patients.

    British Society for Antimicrobial Chemotherapy Spring Conference, May 2024

  4. 04
    Clinical education·Sole author

    Abdou Ali, O.A.M. (2024). Prescribing Anticoagulants.

    Geeky Medics

  5. 05
    Clinical education·Sole author

    Abdou Ali, O.A.M. (2024; updated 2026). Insulin Prescribing.

    Geeky Medics

Qualifications

Education and academic distinctions

MPharm (Hons) Pharmacy — First Class

University of Nottingham, United Kingdom

2019 – 2023
  • Dean's Excellence Scholarship (2020–2023) and High Achiever's Scholarship (2019), awarded for academic performance in the top 10% of the cohort.
  • Achieved the highest cohort mark in Cancers, Renal and Endocrine Diseases; Cardiovascular; and Being a Pharmacist.
  • Dissertation: investigation of the anti-tumour effects of benzoprims — evaluated compound activity in RAS-mutant colorectal cancer cell lines using mammalian cell culture, MTT and clonogenic assays.
  • Further research training in survey design and SPSS analysis, critical review of CRISPR-Cas9 in cystic fibrosis, and an antimalarial drug-target and lead-design proposal.

A Levels — 3 A*

IISM Secondary School, Selangor, Malaysia

2016 – 2018
  • Mathematics, Biology and Chemistry.
Practice

Clinical and professional experience

Senior Rotational Pharmacist (Band 7)

London North West University Healthcare NHS Trust

Dec 2025 – Present
  • Apply clinical pharmacology and evidence-based guidance to support safe, patient-centred use of medicines across acute hospital rotations.
  • Developed a local Trust guideline on the use of rituximab across wards and clinics, covering prescribing, screening and administration, to standardise practice for pharmacy, medical and nursing staff.
  • Supervise, manage and mentor junior pharmacists and trainee pharmacists across rotations.
  • Translate complex clinical and medicines information into clear, evidence-based recommendations for patients and multidisciplinary teams.
Capability

Research methods and technical skills

Population and quantitative research

Survey design and participant recruitment · SPSS · Quantitative data interpretation · Real-world patient-generated data · Critical appraisal and evidence synthesis

Experimental pharmacology

Mammalian cell culture · MTT and clonogenic assays · Aseptic technique · Pharmaceutical formulation · Colorimetry and titration · Spectrophotometry and thin-layer chromatography

Biomaterials and laboratory tools

GelMA hydrogel synthesis · Stereolithography and 3D construct design · ImageJ · Chimera · ChemDraw · TinkerCAD

Recognition and engagement

Awards, teaching and languages

Awards

  • Dean's Excellence Scholarship, University of Nottingham — top 10% of cohort (2020–2023).
  • High Achiever's Scholarship, University of Nottingham (2019).
  • Nottingham Advantage Award for extracurricular and intercultural development (2021).

Teaching and mentoring

Student Mentor — IntoUniversity Nottingham East

2022 – 2023

Planned tailored educational sessions supporting a young person's academic, social and personal development.

Primary School Science Volunteer — Arnbrook Primary School

2021 – 2022

Co-designed and delivered accessible science sessions to build pupils' confidence and interest in higher education.

Languages

English (fluent) · Arabic (fluent) · Turkish (fluent) · French (conversational)

Enquiries

Contact

Available to discuss doctoral projects, supervision and research collaboration in pharmacoepidemiology, medication safety and population health.

Email
ola.asem@nhs.net
Telephone
+44 7510 340637
Location
London, United Kingdom
Registration
GPhC Reg. No. 2236654
Profiles
LinkedInPubMedCV (PDF)